您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2016, Vol. 54 ›› Issue (6): 16-21.doi: 10.6040/j.issn.1671-7554.0.2015.1096

• • 上一篇    下一篇

CXCL16基因沉默减轻ox-LDL对小鼠足细胞损伤

王雪1,李倩1,王莉1,孙书珍1,马爱华2   

  1. 山东大学附属省立医院 1.小儿肾脏风湿免疫科;2.小儿神经科, 山东 济南 250021
  • 收稿日期:2015-11-10 出版日期:2016-06-20 发布日期:2016-06-20
  • 通讯作者: 孙书珍. E-mail:ssztml@163.com E-mail:ssztml@163.com
  • 基金资助:
    山东省自然科学基金(ZR2010HM110);山东省科技发展计划(2014GGH218009);山东省自然科学基金(ZR2015HM009)

CXCL16 gene silencing alleviates injury of mouse podocytes treated with the oxidized low-density lipoprotein

WANG Xue1, LI Qian1, WANG Li1, SUN Shuzhen1, MA Aihua2   

  1. 1. Department of Paediatric Nephrology &
    Rheumatism and Immunology, 2. Department of Paediatric Neurology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China
  • Received:2015-11-10 Online:2016-06-20 Published:2016-06-20

摘要: 目的 探讨CXC趋化因子配体16(CXCL16)基因沉默在减轻氧化低密度脂蛋白(ox-LDL)对足细胞损伤中的作用。 方法 小鼠CXCL16基因短发卡RNA(shRNA)慢病毒及阴性对照慢病毒转染足细胞,Real-time PCR、Western blotting检测转染效率。CCK8法检测转染后足细胞活力。将转染后足细胞分为4组培养和处理,即阴性对照组(NC组)、ox-LDL组、CXCL16-shRNA组、ox-LDL+CXCL16-shRNA 组。总胆固醇含量测定估计细胞内脂质沉积,Western blotting检测CXCL16及β1整合素变化,并检测活性氧(ROS)的表达。 结果 CXCL16-shRNA慢病毒转染后,CXCL16 mRNA抑制率约70%(P=0.008),CXCL16蛋白抑制率约60%(P=0.008)。CXCL16-shRNA组及NC组细胞活力差异无统计学意义(P=0.712)。ox-LDL+CXCL16-shRNA 组较ox-LDL组细胞内脂质沉积减少(P<0.001),β1整合素表达量增加(P=0.004),ROS产生减少(P<0.001)。 结论 CXCL16基因沉默可减少ox-LDL作用后ROS表达量,并增加β1整合素的表达,发挥足细胞保护作用。

关键词: CXC趋化因子配体16, 短发卡RNA, β1整合素, 活性氧, 足细胞, 氧化低密度脂蛋白

Abstract: Objective To investigate the role of chemokine ligand 16(CXCL16)gene silencing on alleviating injury of podocytes treated with oxidized low-density lipoprotein(ox-LDL). Methods The mouse podocytes were transfected with CXCL16 gene short hairpin RNA(shRNA)lentivirus vector and negative control lentivirus vector. The protein and mRNA expressions of CXCL16 were determined with Western blotting and Real-time PCR. The vitality of podocytes was detected with CCK8 assay. The mouse podocytes(cell line)were divided into 4 groups: negative control group(NC group), ox-LDL group, CXCL16-shRNA group, and ox-LDL+CXCL16-shRNA group. The total cholesterol was detected with cholorimetric detection to measure intracelluar lipid accumulations. The expressions of CXCL16 and integrin-β1 were detected with Western blotting. The expression of ROS was detected with ROS Deep Red Dye. Results The inhibition rate of CXCL16 mRNA was about 70%, and that of CXCL16 protein was about 60%, compared to the negative control(both P=0.008). CCK8 revealed no significant difference in the vitality of podocytes between NC group and CXCL16-shRNA group(P=0.712). Compared to the ox-LDL group, in the ox-LDL+CXCL16-shRNA group, the intracelluar lipid accumulations were reduced(P<0.001), integrin-β1 was increased(P=0.004), 山 东 大 学 学 报 (医 学 版)54卷6期 -王雪,等.CXCL16基因沉默减轻ox-LDL对小鼠足细胞损伤 \=-and ROS was reduced(P<0.001). Conclusion CXCL16 gene silencing is likely to play an important role for podocytic protection after the treatment of ox-LDL by reducing the synthesis of ROS and elevating the expression of integrin-β1.

Key words: Chemokine ligand 16, Reactive oxygen species, Integrin-β1, Podocyte, Oxidized low-density lipoprotein, Short hairpin RNA

中图分类号: 

  • R726.9
[1] Diez-Sampedro A, Lenz O, Fornoni A, et al. Podocytopathy in diabetes: a metabolic and endocrine disorder[J]. Am J Kidney Dis, 2011, 58(4): 637-646.
[2] Gutwein P, Abdel-Bakky MS, Schramme A, et al. CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein[J]. Am J Pathol, 2009, 174(6): 2061-2072.
[3] 王聪, 孙书珍, 甄军晖, 等. CXCL16在阿霉素肾病小鼠中的作用及辛汀对其影响的作用[J]. 山东大学学报(医学版), 2015, 53(9): 24-29. WANG Cong, SUN Shuzhen, ZHEN Junhui, et al. Role of CXCL16 in mice with adriamycin induced nephropathy and the protective effects of simvastatin[J]. Journal of Shandong University(Health Sciences), 2015, 53(9): 24-29.
[4] Wang L, Sun S, Zhou A, et al. Ox-LDL-induced lipid accumulation in glomerular podocytes: role of IFN-γ, CXCL16, and ADAM10[J]. Cell Biochem Biophys, 2014, 70(1): 529-538.
[5] 许艺怀, 孙书珍, 甄军晖, 等. CXCL16和oxLDL在阿霉素肾病小鼠中的变化及意义[J]. 山东大学学报(医学版), 2014, 52(5): 68-72. XU Yihuai, SUN Shuzhen, ZHEN Junhui, et al. Role of CXCL16 and ox-LDL in mice with adriamycin induced nephropathy[J]. Journal of Shandong University(Health Sciences), 2014, 52(5): 68-72.
[6] Norlander AE, Saleh MA, Madhur MS, et al. CXCL16: a chemokine causing chronic kidney disease[J]. HHS Author Manuscriopts, 2013, 62(6): 1008-1010.
[7] Gutwein P, Abdel-Bakky MS, Doberstein K, et al. CXCL16 and ox-LDL are induced in the onset of diabetic nephropathy[J]. J Cell Mol Med, 2009, 13(9b): 3809-3825.
[8] Daehn I, Casalena G, Zhang T, et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis[J]. J Clin Invest, 2014, 124(4): 1608-1621.
[9] Herman-Edelstein M, Scherzer P, Tobar A, et al. Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy[J]. J Lipid Res, 2014, 55(3): 561-572.
[10] Dai R, Lin Y, Liu H, et al. A vital role for Angptl3 in the PAN-induced podocyte loss by affecting detachment and apoptosis in vitro[J]. BMC Nephrol, 2015, 16: 38, doi:10.1186/s12882-015-0034-4.
[11] Pozzi A, Jarad G, Moeckel GW, et al. β1 integrin expression by podocytes is required to maintain glomerular structural integrity[J]. Dev Biol, 2008, 316(2): 288-301.
[12] Müller-Deile J, Schiffer M. The podocyte power-plant disaster and its contribution to glomerulopathy[J]. Front Endocrinol, 2014, 5: 209, doi: 10.3389/fendo.2014.00209.
[13] Zorov DB, Juhaszova M, Sollott SJ, et al. Mitochondrial reactive oxygen species(ROS)and ROS-induced ROS release[J]. Physiol Rev, 2014, 94(3): 909-950.
[1] 付洁琦,张曼,张晓璐,李卉,陈红. Toll样受体4抑制过氧化物酶体增殖物激活受体γ加重血脂蓄积的分子机制[J]. 山东大学学报 (医学版), 2020, 1(7): 24-31.
[2] 赵作辉,李翠玲,王道光,王风芹,曲宏懿,丁森泰,巩晶,吕家驹,杨静华. MnSOD乙酰化对肾透明细胞癌786-O细胞增殖、凋亡的影响[J]. 山东大学学报(医学版), 2017, 55(9): 31-35.
[3] 李帅,王雅琳,孙忠文,朱梅佳. Nod样受体蛋白3炎性体在2型糖尿病脑微血管内皮细胞中的变化及变化机制[J]. 山东大学学报(医学版), 2017, 55(3): 6-11.
[4] 王聪, 孙书珍, 甄军晖, 李倩, 许艺怀. CXCL16在阿霉素肾病小鼠中的表达及辛伐他汀对其的影响[J]. 山东大学学报(医学版), 2015, 53(9): 24-29.
[5] 刘辉, 陈桐帅, 李娜, 王舒健, 李静媛, 卜培莉. Sirt3对人脐静脉内皮细胞衰老的影响[J]. 山东大学学报(医学版), 2015, 53(5): 41-45.
[6] 杨璐, 周英泽, 倪明, 樊秀双, 满建梅, 郭军堂. β-synuclein对Ⅱ型囊泡单胺转移体表达的促进作用[J]. 山东大学学报(医学版), 2015, 53(4): 61-64.
[7] 邱宗建,杨娟,宋强 . 地西他滨对同步化的G0/G1期MDS-L细胞系线粒体功能的影响[J]. 山东大学学报(医学版), 2014, 52(5): 5-9.
[8] 许艺怀1,孙书珍1,甄军晖2,李倩1,王聪1. CXCL16和ox-LDL在阿霉素肾病小鼠中的变化及意义[J]. 山东大学学报(医学版), 2014, 52(5): 68-72.
[9] 郝凤成1,2,苏中华1,3. 自噬在ox-LDL诱导炎症反应中的保护作用[J]. 山东大学学报(医学版), 2014, 52(4): 30-34.
[10] 孙高英1,王小元2,张晓金1,郝秀玉1,郭元芳1,王晓1,毕文祥1. N-乙酰半胱氨酸对子宫颈癌细胞紫杉醇耐药性的影响[J]. 山东大学学报(医学版), 2013, 51(3): 42-47.
[11] 常相帝1,王杰1,李冰1,甄军晖2,姜虹3,胡昭1. FK506对早期糖尿病肾病大鼠足细胞损伤的保护作用[J]. 山东大学学报(医学版), 2012, 50(6): 20-25.
[12] 蒋崇辉1,艾小红2,杨小红3,罗琼3,曹建国3. 活性氧生成在8-硝基白杨素诱导人胃癌SGC-7901细胞凋亡中的作用[J]. 山东大学学报(医学版), 2012, 50(2): 34-37.
[13] 董传芳1,刘雪平1,王美霞1,徐松1,殷青青1,孙志坚1,游丽2. 糖基化终末产物对SH-SY5Y细胞氧化应激及凋亡的影响[J]. 山东大学学报(医学版), 2012, 50(1): 9-.
[14] 孙荣国1,徐龙进2,胡鸿雁1,才晓君1,王梦1,吕以杰1. 多聚肌苷酸在兔动物模型中抗动脉粥样硬化的作用及对血管组织LOX-1表达的影响[J]. 山东大学学报(医学版), 2011, 49(7): 78-82.
[15] 朱薇1,2,潘芳1,江虹1,于洪鸾1,孙琳1,王力1. 氯胺酮对食蟹猴大脑血管病理及NADPH氧化酶表达的影响[J]. 山东大学学报(医学版), 2011, 49(4): 47-51.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!